EGFr dinucleotide repeat polymorphism in non-small cell lung cancer.

被引：0
|
作者：
Dubey, S
Miller, J
Stephenson, P
Keller, SM
Johnson, DH
Schiller, JH
Kolesar, JM
机构：
[1] Univ Wisconsin, Eastern Cooperat Oncol Grp, Madison, WI USA
[2] Univ Wisconsin, Sch Pharm, Madison, WI USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Vanderbilt Univ, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9585
引用
收藏
页码：856S / 856S
页数：1
相关论文
共 50 条
  • [1] EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer
    Dubey, Sarita
    Stephenson, Patricia
    Levy, Donna E.
    Miller, Judith A.
    Keller, Steven M.
    Schiller, Joan H.
    Johnson, David H.
    Kolesar, Jill M.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (05) : 406 - 412
  • [2] Frequency of EGFR mutations in peruvian patients with non-small cell lung cancer.
    Gomez de la Torre, Juan C.
    Storace, Angelo
    Piscocha, Christian
    Landa, Jose
    Roe, Carlos
    Roe, Eduardo
    Barletta, Claudia
    Mas, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Shorter EGFR Dinucleotide Repeat Length Predicts Better Response of Patients with Advanced Non-small Cell Lung Cancer to EGFR Tyrosine Kinase Inhibitor
    Bin Chen
    Jie Luo
    Weiqing Gu
    Li Shen
    Heyong Wang
    Songwen Zhou
    Cell Biochemistry and Biophysics, 2015, 73 : 799 - 804
  • [4] Shorter EGFR Dinucleotide Repeat Length Predicts Better Response of Patients with Advanced Non-small Cell Lung Cancer to EGFR Tyrosine Kinase Inhibitor
    Chen, Bin
    Luo, Jie
    Gu, Weiqing
    Shen, Li
    Wang, Heyong
    Zhou, Songwen
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 73 (03) : 799 - 804
  • [5] Advanced non-small cell lung cancer.
    Edelman M.J.
    Khanwani S.L.
    Current Treatment Options in Oncology, 2001, 2 (1) : 51 - 62
  • [6] Prognostication in non-small cell lung cancer.
    Gagnon, Bruno
    Gioulbasanis, Ioannis
    Cohen, Victor
    Pepe, Carmela
    Small, David I.
    Yang, Lin
    Perdikouri, Eleni Isidora
    Kasymjanova, Goulnar
    Morris, David
    MacDonald, Neil
    Agulnik, Jason Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] The role of EGFR inhibitors as adjuvant therapy for EGFR mutation positive non-small cell lung cancer.
    Xie, Peng
    Tang, Wenjie
    Li, Xiaolin
    Sun, Xindong
    Yu, Jinming
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] EGFR variant III expression in Chinese patients with non-small cell lung cancer.
    Wang, Jie
    Duan, Jianchun
    Bai, Hua
    Yang, Lu
    An, Tongtong
    Wang, Zhijie
    Zhuo, Minglei
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] EGFR mutation analysis in histologic and cytologic specimens of non-small cell lung cancer.
    Sakai, H.
    Akagi, K.
    Sudoh, J.
    Yoneda, S.
    Komagata, H.
    Kurimoto, F.
    Hommura, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 408S - 408S
  • [10] Depression and EGFR mutation status in stage IV non-small cell lung cancer.
    Pirl, W. F.
    Greer, J.
    Bemis, H.
    Heist, R. S.
    Gallagher, E.
    Sequist, L. V.
    Engelman, J. A.
    Traeger, L.
    Lennes, I. T.
    Temel, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345